The Liver Meeting 2020-AASLD/Japan Society of Hepatology Joint Symposium Lean NAFLD

Video Transcription

Video Summary

The ACLD Japan Society of Hepatology Joint Symposium on Lynn Nash underscored the importance of understanding non-alcoholic fatty liver disease, NAFLD, especially in lean individuals, who do not fit the traditional criteria for metabolic risk factors. The prevalence of NAFLD is gradually increasing worldwide, with the PMPLA3 gene polymorphism playing a significant role in liver fat accumulation. Studies have shown that genetic variations, such as PMPLA3 and TM6SF2, interact with metabolic factors to influence the risk and severity of NAFLD. Lean individuals with NAFLD may have a higher genetic predisposition to the disease, with the PNPLA3 Gene's effect being more pronounced in this group. The symposium also highlighted the potential benefits of lifestyle modifications and the importance of considering genetic factors in treatment strategies for NAFLD. Furthermore, insights into gene-environment interactions, epigenetics, and rare genetic disorders were also discussed, emphasizing the need for further research in these areas to improve our understanding of NAFLD pathogenesis. The collaborative efforts between the Japan Society of Hepatology and the American Association for the Study of Liver Diseases aim to advance knowledge in hepatology and promote international cooperation in liver research.

Keywords

ACLD Japan Society of Hepatology

Joint Symposium

NAFLD

lean individuals

genetic variations

lifestyle modifications

treatment strategies

gene-environment interactions

research

hepatology

international cooperation